IN BRIEF: MedPal AI stock rises as "exceptional growth" continues
Medpal AI PLC - London-based digital health and AI company - Says its New Health arm delivered "record trading" on Monday, dispensing over 2,300 prescription orders worth approximately GBP300,000. Notes marketing costs and discounts go towards customers' first orders, but that since July, "repeat orders at every order cycle have generated a positive margin after the cost of medication, and that margin increases from the second order onwards." It expects these to "make a growing contribution" to cashflow as more customers stay beyond introductory orders. Furthermore, Medpal says "a non-bank lender" has sent an indicative term sheet for GBP8 million in funding, and talks continue "with UK clearing banks and specialist lenders regarding a facility secured on the group's receivables." Also highlights its "strong liquidity position," reporting cash, near cash and stock of approximately GBP6.4 million as of Tuesday. Read More